skip to primary navigationskip to content
 

Opportunity to learn about biotech company Gilead Sciences, regulatory affairs and a potential PIPS

last modified Jun 14, 2016 02:16 PM

An Introduction to Regulatory Affairs - Dr Alan Collins, Director of International Regulatory Affairs, Gilead Sciences Ltd

Join us for an enlightening lecture given by Alan Collins, Director of International Regulatory Affairs at Gilead Sciences Ltd. Alan will introduce you to the challenging and diverse topic of regulatory affairs in the pharmaceutical industry and cover some of the aspects they are faced with from day to day. In particular, he will look at some of the issues faced with fraudulent and counterfeit medicines and when looking at promotional affairs and product claim development, as these are the two topics for a potential project with Gilead. 

There is an opportunity to conduct an internship (PIPS) under Alan at Gilead Sciences.

Date: Wednesday 29 June 2016

Time: 14:30-15:30

Venue: Large Lecture Theatre, Plant Sciences

Please visit the GSLS website to book your place.

 

About Gilead: 

Gilead is one of the world's most successful biotech companies with a current market capitalisation of over $150 billion. Gilead Sciences Inc is a leading research-based biopharmaceutical company which discovers, develops and commercialises innovative medicines in life-threatening diseases. Gilead's primary areas of focus include HIV/AIDS, liver diseases, respiratory diseases, cardiovascular/metabolic diseases, inflammation and oncology.

About Alan:

Alan has 18 years of experience in the pharmaceutical industry and is a Director of Regulatory Affairs at Gilead Sciences. Alan's experience covers the many diverse areas of regulatory affairs, plus pricing and reimbursement, medical affairs, business conduct and auditing - he has never had two working days the same and enjoys the variety and challenge of his role.